Polysaccharide isolated from Poria cocos sclerotium induces NF-κB/ Rel activation and iNOS expression in murine macrophages

International Immunopharmacology

Volumn 3, Issue 10-11, 2003, Pages 1353-1362

  Lee, Kun Yeong ^a   Jeon, Young Jin ^a  

^a Chosun University College of Medicine   (South Korea)

Author keywords

iNOS; Macrophages; NF B Rel; Poria cocos

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOPROTEIN; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OCTAMER TRANSCRIPTION FACTOR; POLYSACCHARIDE; SODIUM CARBONATE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR REL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING SITE; CONTROLLED STUDY; DNA BINDING; DRUG ACTIVITY; DRUG ISOLATION; FEMALE; GENE EXPRESSION; GENE INDUCTION; IMMUNOSTIMULATION; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN INDUCTION; REPORTER GENE; SCLEROTIUM (ASCOMYCOTA);

EID: 0041926655     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5769(03)00113-9     Document Type: Article

References (35)

1. Chang H.-M., But P.P.-H. Pharmacology and applications of Chinese material medica. World scientific. vol. 2:1987;875-877. Singapore.
2. Hikino H. Recent research on oriental medicinal plants. Wagner H., Hikino H., Farnsworth N.R. Economic and medicinal plant research. vol. 1:1985;64-65 Academic Press, London.
3. Hattory T., Hayashi K., Nagao T., Furuta K., Ito M., Susuki Y. Studies of antinephritic effects of plant components (3). Effects of pachyman, a main component of Poria cocos Wolf on original-type anti-GBM nephritis in rats and its mechanisms. Jpn. J. Pharmacol. 59:1992;89-96.
4. Tai T., Akita Y., Kinoshita K., Koyama K., Takahashi K., Watanabe K. Anti-emetic principles of Poria cocos. Planta Med. 61(6):1995;527-530.
5. Schinella G.R., Tournier H.A., Prieto J.M., Mordujovich D., Rios J.L. Antioxidant activity of anti-inflammatory plant extracts. Life Sci. 70(9):2002;1023-1033.
6. Kaminaga T., Yasukawa K., Kanno H., Tai T., Nunoura Y., Takido M. Inhibitory effects of lanostane-type triterpene acids, the components of Poria cocos, on tumor promotion by 12-O-tetradecanoylphorbol-13-acetate in two-stage carcinogenesis in mouse skin. Oncology. 53(5):1996;382-385.
7. Ukiya M., Akihisa T., Tokuda H., Hirano M., Oshikubo M., Nobukuni Y.et al. Inhibition of tumor-promoting effects by poricoic acids G and H and other lanostane-type triterpenes and cytotoxic activity of poricoic acids A and G from Poria cocos. J. Nat. Prod. 65(4):2002;462-465.
8. Kanayama H., Togami M., Adachi N., Fukai Y., Okumoto T. Studies on the antitumor active polysaccharides from the mycelia of Poria cocos Wolf: III. Antitumor activity against mouse tumors. Yakugaku Zasshi. 106(4):1986;307-312.
9. Rhee S.D., Cho S.M., Park J.S., Han S.B., Jeon Y.J., Kim H.M.et al. Chemical composition and biological activities of immunostimulants purified from alkali extract of Poria cocos sclerotium. Korean J. Mycol. 27(4):1999;293-298.
10. Yu S.J., Tseng J. Fu-Ling, a Chinese herbal drug, modulates cytokine secretion by human peripheral blood monocytes. Int. J. Immunopharmacol. 18(1):1996;37-44.
11. Palmer R.M., Ashton D.S., Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 333(6174):1988;664-666.
12. Hibbs J.B. Jr., Taintor R.R., Vavrin Z. Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite. Science. 235(4787):1987;473-476.
13. Stuehr D.J., Nathan C.F. Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J. Exp. Med. 169(5):1989;1543-1555.
14. MacMicking J.D., Nathan C., Hom G., Chartrain N., Fletcher D.S., Trumbauer M.et al. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell. 81(4):1995;641-650.
15. Yim C.Y., Bastian N.R., Smith J.C., Hibbs J.B. Jr., Samlowski W.E. Macrophage nitric oxide synthesis delays progression of ultraviolet light-induced murine skin cancers. Cancer Res. 53(22):1993;5507-5511.
16. Farias-Eisner R., Sherman M.P., Aeberhard E., Chaudhuri G. Nitric oxide is an important mediator for tumoricidal activity in vivo. Proc. Natl. Acad. Sci. U. S. A. 91(20):1994;9407-9411.
17. Xie K., Huang S., Dong Z., Juang S.H., Gutman M., Xie Q.W.et al. Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells. J. Exp. Med. 181(4):1995;1333-1343.
18. 15N]nitrate in biological fluids. Anal. Biochem. 126(1):1982;131-138.
19. Chomczynski P., Mackey K. Substitution of chloroform by bromo-chloropropane in the single-step method of RNA isolation. Anal. Biochem. 225(1):1995;163-164.
20. Jeon Y.J., Han S.H., Lee Y.W., Yea S.S., Yang K.H. Inhibition of NF-kappa B/Rel nuclear translocation by dexamethasone: mechanism for the inhibition of iNOS gene expression. Biochem. Mol. Biol. Int. 45(3):1998;435-441.
21. Pierce J.W., Lenardo M., Baltimore D. Oligonucleotide that binds nuclear factor NF-kappa B acts as a lymphoid-specific and inducible enhancer element. Proc. Natl. Acad. Sci. U. S. A. 85(5):1988;1482-1486.
22. Annweiler A., Zwilling S., Hipskind R.A., Wirth T. Analysis of transcriptional stimulation by recombinant Oct proteins in a cell-free system. J. Biol. Chem. 268(4):1993;2525-2534.
23. Xie Q.W., Qhisnant R., Nathan C. Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon-g and bacterial lipopolysaccharide. J. Exp. Med. 177:1993;1779-1784.
24. Jeon Y.J., Yang K.H., Pulaski J.T., Kaminski N.E. Attenuation of inducible nitric oxide synthase gene expression by delta 9-tetrahydrocannabinol is mediated through the inhibition of nuclear factor-kappa B/Rel activation. Mol. Pharmacol. 50(2):1996;334-341.
25. Xie H., Chiles T.C., Rothstein T.L. Induction of CREB activity via the surface Ig receptor of B cells. J. Immunol. 151:1993;880-889.
26. Dunnett M. A multiple comparison procedure for comparing several treatments with a control. J. Am. Stat. Assoc. 50:1955;1096-1121.
27. Morrison D.C., Jacobs D.M. Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharides. Immunochemistry. 13(10):1976;813-818.
28. Xie Q.W., Kashiwabara Y., Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J. Biol. Chem. 269(7):1994;4705-4708.
29. Lin Y.Z., Yao S.Y., Veach R.A., Torgerson T.R., Hawiger J. Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence. J. Biol. Chem. 270(24):1995;14255-14258.
30. Novotney M., Chang Z.L., Uchiyama H., Suzuki T. Protein kinase C in tumoricidal activation of mouse macrophage cell lines. Biochemistry. 30(22):1991;5597-5604.
31. Muroi M., Suzuki T. Role of protein kinase A in LPS-induced activation of NF-kappa B proteins of a mouse macrophage-like cell line, J774. Cell. Signal. 5(3):1993;289-298.
32. Goyert S.M., Ferrero E., Rettig W.J., Yenamandra A.K., Obata F., Le Beau M.M. The CD14 monocyte differentiation antigen maps to a region encoding growth factors and receptors. Science. 239(4839):1988;497-500.
33. Thornton B.P., Vetvicka V., Pitman M., Goldman R.C., Ross G.D. Analysis of the sugar specificity and molecular location of the beta-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18). J. Immunol. 156(3):1996;1235-1246.
34. Hynes R.O. Integrins: versatility, modulation, and signaling in cell adhesion. Cell. 69(1):1992;11-25.
35. Kopp E.B., Medzhitov R. The Toll-receptor family and control of innate immunity. Curr. Opin. Immunol. 11(1):1999;13-18.